Anavex Life Sciences
AVXL
#9983
Rank
โ‚น7.08 B
Marketcap
โ‚น76.47
Share price
-12.42%
Change (1 day)
-75.91%
Change (1 year)

EPS for Anavex Life Sciences (AVXL)

EPS in 2026 (TTM): -โ‚น13.17

According to Anavex Life Sciences 's latest financial reports the company's current EPS (TTM) is -โ‚น14.03. In 2025 the company made an earnings per share (EPS) of -โ‚น43.02.

EPS history for Anavex Life Sciences from 2025 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น13.17-69.38%
2025-โ‚น43.02

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ligand Pharmaceuticals
LGND
โ‚น242.23-1,826.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
โ‚น140.29-1,100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-โ‚น706.13 4,933.33%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-โ‚น126.26 800.00%๐Ÿ‡บ๐Ÿ‡ธ USA